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Abstract A frequency volume chart is a simple, easy-to-use, non-invasive tool
that is useful in the assessment of patients with lower urinary tract symptoms.
Though more sophisticated techniques are now available for diagnosis, the
frequency volume chart should still be considered the first line investigation. In
this review we summarize the indications and value of this age old investigation.
Urologists and primary care physicians should use the frequency volume chart more
frequently in their practice.
ª 2005 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
The frequency volume (FV) chart is the systematic
registration of voiding habits by patients in their
own environment for a specified period of time.1
FV charts have been used for many years, the first
charts being introduced in the late 1970s.2 In these
patients were asked to record with an ‘X’ each
time they voided at night. The first advance came
when the 24 h period was divided into daytime
when the patient is awake, and night-time when
asleep, i.e. when the patient was in bed with the
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dark.2 Such a chart is illustrated in Fig. 1 below.
Frequency chart
Later modifications included asking the patient to
document fluid intake (type and volume), the
volumes of urine voided, the number of episodes
of urgency, incontinence and the use of inconti-
nence aids such as pads.
No standard FV chart exists; they vary from the
simple charts measuring the total number of voids
in a day, to urinary diaries which record fluid
intake, frequency, volume, urge episodes, pad
usage, and patient activities in relation to their
lower urinary tract symptoms (LUTS).2 FV chartsblished by Elsevier Ltd. All rights reserved.
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is required to fill in the chart; initial charts were
commonly over a 7-day period2 though 24 or 48 h is
usual nowadays.1 A 1e3 day chart is commonly used
in clinical practice and evidence has shown this is as
useful as those charts kept for longer periods.3
Patients once suitably counselled can easily fill
these charts accurately.4 Studies have shown that
the information obtained from FV charts, such as
voided volumes, correlate well with that obtained
from invasive methods of assessing voiding
(dys)function such as urodynamic study.5,6 Despite
the many advantages of FV charts they are not
widely used in routine urological practice in the
assessment and management of men with LUTS.
This contrasts to the assessment of women with lower
urinarytractdysfunctionwhereFVchartsarewidelyused.
The purpose of a FV chart is to obtain objective
information about a patient’s urinary symptoms
that would be difficult to elicit from the history
alone. They are useful in quantifying symptoms at
baseline as part of the diagnostic work up of
a patient with LUTS and prior to lifestyle, medical
or surgical intervention.2,7e9
In this review we examine the role of FV charts
in the assessment and management of men with
LUTS. The role of FV charts in women and children
will not be discussed.
Role of FV charts in the assessment
and diagnosis of men with LUTS
The urinary bladder has two functions: to store and
to empty urine.10 FV charts are an inexpensive and
easy-to-use method of assessing bladder function.11
DAY NIGHT 
DAY 1 XXX  
DAY 2 XX  
DAY 3 X + 
DAY 4 X ++ 
DAY 5 XX  
DAY 6 XXXX + 
DAY 7 X + 
AVERAGE   
Figure 1 Simple 7 day frequency chart recording
micturition and leaking episodes (adapted from Abrams
and Klevmark2). Each time you pass your urine, mark the
chart with an X. If you leak or wet the bed, mark the
chart with aC. Keep the record for 7 consecutive days
(or as long as possible). ‘Day’ is from the time you get up
until the time you go to bed.LUTS are experienced by one half of all men over
the age of 65.12 The term LUTS has largely replaced
‘prostatism’ which tends to suggest that these
symptoms are due the prostate alone.13 Although
benign prostatic hyperplasia (BPH) is probably the
most common cause it is rarely the sole culprit. The
bladder, kidneys, brain, heart, and urine all con-
tribute. Bladders can be small, stiff (poorly com-
pliant), weak (detrusor failure) or overactive, as a
result of long-term obstruction to the outlet by
prostatic enlargement. Any of these bladder con-
ditions may also occur independently and be the
primary cause of a man’s LUTS. It is important that
the assessment of men with LUTS does not focus on
bladder outflow obstruction alone and all symptoms
are considered.
It is known that information from subjective
questionnaires e.g. International Prostate Symp-
tom Score (IPSS and self-reporting of symptomsmay
not always be accurate.14 It is for these reasons
both the EAU and AUA clinical practice guidelines
on BPH and LUTS recommend the use of FV charts
when assessingmenwith LUTS in addition to the use
of symptom questionnaires. FV charts have been
used extensively in the assessment of nocturia15,16
and have confirmed a relation between nocturnal
urine production and voiding frequency in older
men.17 Studies using FV charts have shown that 25%
of older men suffer from severe nocturia (O3
nocturia episodes per night) and produce larger
volumes of urine at night (nocturnal polyuria)
compared to men who do not have such nocturia.18
A 3-day FV chart would be sufficient to detect
nocturnal polyuria and therefore to be of value in
evaluating patients with LUTS.18 This is a significant
finding as treatments directed primarily at the
prostate with medication or surgery in this group
may be less effective in reducing nocturia. Prior to
better understanding of nocturia many patients
presenting with this symptom would have had
a transurethral resection of the prostate, some-
times with poor results as the pathology is not
bladder outflow obstruction. Poor agreement exists
between the responses on the FV charts and the
IPSS question on nocturia suggesting that the IPSS is
not a good indicator of nocturia, further supporting
the use of FV charts in the assessment of nocturia.19
Five diagnostic prototypes of FV charts have
therefore been described by Nordling10 which, in
conjunction with patient history, may help cate-
gorize patients:
Type 1 with normal single volumes and normal
24 h volume denotes normal bladder function.
Type 2 with normal single volumes and in-
creased 24 h volume denotes normal bladder
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urinary frequency, which may be due to
excessive intake or secondary to diabetes or
renal insufficiency.
Type 3 with small single volumes during the day
and night is usually due to motor or sensory
urgency.
Type 4 with large morning first void volume and
variable small volumes during the day is usually
seen in psychosomatic conditions.
Type 5with increased daytime urinary frequency
and nocturia but with normal single and 24 h
volumes suggest bladder outflow obstruction,
typically due to BPH.
The validity and reliability of FV charts has been
thoroughly investigated by urodynamics.5,6 In men
with LUTS suggestive of benign prostatic hyper-
plasia (BPH), filling cystometric capacities are
strongly associated with maximal and mean voided
volumes derived from FV charts.6 It is known that
functional bladder capacity (FBC), defined as the
largest single voided volume, declines with age, and
this decline in FBC is one of the diagnostic predictors
for BPH.20 FV charts allow us to evaluate FBC as well
as provide information on urinary frequency, an
important symptom as many men with BPH have an
overactive bladder secondary to outlet obstruction.20e22
The role of FV charts in monitoring
treatment interventions
Completing serial FV charts before and after treat-
ment interventions is a cheap, non-invasive and
effective method of monitoring LUTS regardless of
the underlying pathology. Involving patients in this
way by asking them to complete FV charts may help
increase compliance with the current behavioural
or medical intervention strategy as if it is effective,
as they can personally quantify their improved
urinary habits. This is important as discontinuation
rates of medical therapy such as alpha-blockers can
be as high as 25% in the first three months.
Information obtained from FV charts, such as
voided volume or bladder capacity, can be used as
effective outcome measures in clinical trials for
men with LUTS. They have been used in many
randomised placebo controlled trials to supplement
themeasurement of outcomealongside for example
the IPSS, uroflow, post-void residual measurement
and urodynamics.7 Trials involving behavioural,
medical and surgical therapies have all used the
data obtained on FV charts as outcome measures.
Studies have used FV charts to assess urinary
urge incontinence in older adults.23,24 Frequencyof urinary accidents was shown to be consistently
reduced after biofeedback, pelvic muscle floor
exercises, scheduled voiding, and other behaviou-
ral strategies, with the use of patient-recorded FV
charts. Posterior tibial nerve stimulation,25,26 pel-
vic floor electrical stimulation,27 and sacral neuro-
modulation28 have all been assessed in the
treatment of urinary incontinence using FV charts
in combination with quality of life questionnaires
(such as I-QoL and SF-36), pad tests, and urody-
namic parameters.
In men with nocturnal polyuria and nocturia, FV
charts have shown that furosemide and desmopres-
sin result in a significant reduction in night-time
frequency and nocturnal voided volume compared
to placebo.29,30 These studies defined nocturia as
the number of night-time urinary voiding episodes,
and polyuria as the production ofO33% of the 24 h
urine volume overnight, averaged over a 1-week
period. Without the use of FV charts to record
urinary frequency and volume measurements, these
studieswouldhavebeenmuchmoredifficult toperform.
FV charts have also confirmed that bicaluta-
mide, a non-steroidal anti-androgen, has no sig-
nificant benefit over placebo in the treatment of
BPH.31 In this study prostate volume (using trans-
rectal ultrasound planimetry), urinary flow rates
(using an uroflowmeter), and pressure-flow exami-
nations (using urodynamics), were used in con-
junction with FV charts to assess treatment effect.
Surgical techniques such as transurethral needle
ablation of the prostate (TUNA) have been shown
to be of value in the management of BPH when
assessing symptom impact with the American
Urological Association (AUA)-7 symptom index
and an added quality of life question, the AUA
BPH-Impact Index, and a sexual function score.
Objective improvement after TUNA was shown
using free-flow uroflowmetry, post-void residual
urine volume, and pressure-flow urodynamics; FV
charts confirmed significantly decreased daytime
frequencies and nocturia in patients after TUNA
compared to baseline.
Conclusion
FV charts are non-invasive, inexpensive, and easy-
to-use. They are a useful tool in the assessment,
diagnosis, and monitoring of interventions in men
with LUTS; however, their role in current practice
is ill defined. FV charts have been shown to provide
objective information regarding fluid intake, void-
ing patterns both day and night and inconti-
nence.10 Much of this information is difficult to
obtain from the history alone.
150 P. Sooriakumaran et al.Although recommended by the EAU and AUA, FV
charts are not widely used. This is more likely to be
due to doctors not giving patient charts to complete
and relying on history and flow rates, rather than
patients failing to complete them. In selected cases
this may have an implication for themanagement of
specific patients. Despite their simplicity FV charts
are useful and their use should be encouraged, both
in primary care and specialist practice.
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